Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this phase III study is to compare the efficacy and safety of the
fixed combination of pyronaridine artesunate (Pyramax®, PA) with that of Coartem® (artemether
lumefantrine, AL) in children and adults with uncomplicated P falciparum malaria in Africa
and South East Asia.